ECG recording

2. An introduction to AliveCor and
KardiaMobile Technology

3. 3
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
About AliveCor
Transforming
cardiological
care using AI &
deep learning
Investors
include Omron,
Mayo clinic,
Khosla
ventures and
Qualcomm
HQ in
Mountain view
California, USA.
Present in 30+
Countries
Alivecor products
had been tested in
about 40 clinical
studies published
in various peer-
reviewed journals.
KardiaBand is
the first FDA-
cleared medical
device
accessory for
Apple Watch.

4. 4
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
AliveCor was
recognized as a
2015 Tech Pioneer
by the World
Economic Forum
One of the 50
Smartest
Companies in 2015
by the MIT
Technology Review.
Ranked as “World's
Most Innovative
Companies”
By Fast Company
About AliveCor

5. 5
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Corporate Overview

6. 6
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
History
• Founded in 2011 by physician and inventor, Dr. Dave Albert
• Dr. Albert developed an FDA-cleared smartphone case that
worked as a single lead ECG - in 2012
• In 2019, AliveCor received FDA clearance for KardiaMobile 6L

7. 7
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.

8. 8
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Kardia Mobile

9. 9
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
 KardiaMobile 6L delivers EKG leads I, II, III, aVL, aVR, and aVF.
 Detects AFib, Bradycardia, Tachycardia & Normal heart rhythm
 6-lead EKG gives your doctor more detailed heart information
 Provides doctors visibility into certain arrhythmias that are leading indicators of cardiovascular disease
EKG CHARACTERISTICS
 Six Lead ECG
 10 mV peak-to-peak input dynamic range
 30 second to 5 minute recording duration
 300 samples per second sampling rate
 14 bit resolution
Kardia Mobile
The FDA-cleared KardiaMobile device is the most clinically validated personal ECG
solution in the world

10. 10
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Kardia Mobile
1 80 37
Million
Users
Million
ECG
Countries

11. 11
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Kardia Pro
KardiaPro
Remote Patient
Monitoring that
doesn’t waste
your time.
Free to your practice.
No hardware to buy or
sell.
HIPAA compliant web-
based portal for secure
ECG and blood pressure
review
Streamlined ECG and
blood pressure
interpretation with no
data overload

12. 12
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Kardia Station
Screen patients faster
and effectively
A self check/manned kiosk in
hospitals for the patients
Recorded inputs shared with
hospitals and patients
Kardia station in
Hospitals a smooth and
Quick health check up for
in and out patients

13. 13
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Diagnostics
A lot of waiting
time before a
patient meets a
Doctor
KM ECG to be part
of the diagnostics
before meeting the
doctor
Potentially
identifying people
with possible
cardiac problems
1000 People scanned/Month 100 People identified at a
potential health risk
10 of them will turn up for
complete medical care
including surgery
A 10% identification will boost the hospital revenue at almost no additional cost of implementation

14. 14
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Clinical Studies

15. 15
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Research

16. 16
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.

17. 17
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.

18. 18
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Value Proposition

19. 19
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Why Clinicians Recommend Kardia?
Patients are engaged
in their own healthcare
Easy-to-use, portable device allows patients
to take action when they feel symptoms.
Early detection
at their fingertips
Instant FDA-cleared detection of normal sinus
rhythm or possible AFib with 30-second ECG.
Immediate feedback giving
patients peace of mind
Patients report peace of mind and feeling more
in control of their heart health.
Convenient short-term
or long-term self-monitoring
Affordable and discrete, patients can easily self-
monitor their heart short-term or long-term.

20. 20
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Global Presence

21. 21
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.

22. 22
© 2020 AliveCor. Company confidential. Information contained herein not to be reproduced, distributed or excerpted.
Thank You